OBJECTIVE
The present study was performed to evaluate the rate of recurrent symptomatic thromboembolism with respect to prothrombotic risk factors and underlying clinical conditions.
METHODS
In a series of 215 consecutively enrolled neonates with arterial ischemic stroke (AIS), the factor V G1691A